GIANT BIOGENE(02367),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02367 GIANT BIOGENE

Closed 07-23 16:08:06

29.180

-0.420

-1.42%

High30.280	Low28.980	Vol6.05M
Open29.700	D1 Closing29.600	Amplitude4.39%
Mkt Cap30.99B	Tradable Cap30.99B	Total Shares1.06B
T/O179.22M	T/O Rate0.57%	Tradable Shares1.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"GIANT BIOGENE","latestPrice":29.18,"timestamp":1784794086003,"preClose":29.6,"halted":0,"volume":6047873,"delay":0,"changeRate":-0.014189189189189245,"floatShares":1061999999,"shares":1061999999,"eps":1.809999,"marketStatus":"Closed","change":-0.42,"latestTime":"07-23 16:08:06","open":29.7,"high":30.28,"low":28.98,"amount":179220946,"amplitude":0.043919,"askPrice":29.2,"askSize":18200,"bidPrice":29.18,"bidSize":32400,"shortable":3,"etf":0,"ttmEps":2.014185,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784856600000},"marketStatusCode":5,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":29.6,"dividendRate":0.047605,"openAndCloseTimeList":[[1784770200000,1784779200000],[1784782800000,1784793600000]],"volumeRatio":1.138956,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367/tweets","defaultTab":"tweets","newsList":[{"id":"2652626428","title":"Jefferies Adjusts Giant Biogene's Price Target to HK$32 From HK$35, Keeps at Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2652626428","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652626428?lang=en_us&edition=fundamental","pubTime":"2026-07-20 12:46","pubTimestamp":1784522810,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding (HKG:2367) has an average rating of buy and mean price target of HK$38.93, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999004311.SGD","BK1207","02367","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144386137","title":"Movement Alert｜Giant Biogene Falls 5.27% in Regular Trading, Trading at HK$27.92","url":"https://stock-news.laohu8.com/highlight/detail?id=1144386137","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144386137?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:42","pubTimestamp":1784256142,"startTime":"0","endTime":"0","summary":"On July 17, Giant Biogene fell 5.27% in regular trading, trading at HK$27.92/share, with turnover of HK$57.65 million.Within the Personal Products sector where Giant Biogene belongs, the overall...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166701025","title":"Movement Alert｜Giant Biogene Rises 5.13% in Regular Trading, Medical Aesthetics Product Matrix Accelerates Commercialization as Institutions Eye Fundamental Inflection Point","url":"https://stock-news.laohu8.com/highlight/detail?id=1166701025","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166701025?lang=en_us&edition=fundamental","pubTime":"2026-07-16 11:22","pubTimestamp":1784172146,"startTime":"0","endTime":"0","summary":"On July 16, Giant Biogene rose 5.13% in regular trading, trading at HKD 29.8/share, with turnover of HKD 126 million, extending gains from the prior session.The rally is driven by the rapid...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139766746","title":"Movement Alert｜Giant Biogene Rises 5.28% in Regular Trading, Medical Aesthetics Matrix Accelerates as Institutions See Inflection Point","url":"https://stock-news.laohu8.com/highlight/detail?id=1139766746","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139766746?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:54","pubTimestamp":1784084050,"startTime":"0","endTime":"0","summary":"On July 15, Giant Biogene rose 5.28% in regular trading, trading at HK$28.26/share, with turnover of approximately HK$72.71 million.On the news front, the company's medical aesthetics product matrix...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147612298","title":"Giant Biogene Shares Surge Over 6% in Session on Medical Aesthetics Expansion and Fading Regulatory Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1147612298","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147612298?lang=en_us&edition=fundamental","pubTime":"2026-07-10 15:00","pubTimestamp":1783666828,"startTime":"0","endTime":"0","summary":"Shares of Giant Biogene (02367) experienced a notable increase during the trading session, rising over 6%. At the time of writing, the stock was up 4.13%, trading at HK$26.22 with a turnover of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","VXUS","BK4588","KCAI","02367","BK4585","BK1207","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103423845","title":"Movement Alert｜Giant Biogene Rises 5.08% in Regular Trading, Medical Aesthetics Dual Certification and Strong 618 Performance Drive Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1103423845","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103423845?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:32","pubTimestamp":1783650770,"startTime":"0","endTime":"0","summary":"On July 10, Giant Biogene rose 5.08% in regular trading, trading at HKD 26.4/share, with turnover of approximately HKD 58.35 million.On the news front, multiple brokerages recently published June...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124340855","title":"Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=1124340855","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124340855?lang=en_us&edition=fundamental","pubTime":"2026-06-29 13:02","pubTimestamp":1782709370,"startTime":"0","endTime":"0","summary":"On June 29, Giant Biogene (02367.HK) rose 6.43% in regular trading, trading at HKD 27.48/share, with turnover of HKD 85.81 million. The rally was driven by better-than-expected 618 promotion results...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164694526","title":"Movement Alert｜Giant Biogene Falls 5.18% in Regular Trading, Profit-Taking After Prior Session Surge Amid Consumer Sector Valuation Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1164694526","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164694526?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:15","pubTimestamp":1782353708,"startTime":"0","endTime":"0","summary":"On June 25, Giant Biogene fell 5.18% in regular trading, trading at approximately HK$24.9 per share, with turnover of HK$33.48 million. The decline followed a 5.45% surge in the prior session...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158856276","title":"Giant Biogene Shares Surge Over 6% in Early Trading, CICC Reiterates Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1158856276","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158856276?lang=en_us&edition=fundamental","pubTime":"2026-06-24 11:30","pubTimestamp":1782271844,"startTime":"0","endTime":"0","summary":"Shares of Giant Biogene (02367) rose more than 6% in early trading. At the time of writing, the stock was up 6.01% to HK$26.46, with a turnover of HK$102 million.Recently, Giant Biogene announced...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","BK1207","LU2488822045.USD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137373409","title":"Movement Alert｜Giant Biogene Rises 5.45% in Regular Trading, Crosslinked Recombinant Collagen Implant Approval Boosts Market Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1137373409","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137373409?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:48","pubTimestamp":1782269281,"startTime":"0","endTime":"0","summary":"On June 24, Giant Biogene rose 5.45% in regular trading, trading at 26.22 HKD/share, with turnover of approximately 73.63 million HKD. The stock outperformed its Personal Products peers, all of which...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196139233","title":"Giant Biogene Shares Surge Over 4% Intraday Following Approval of Key Medical Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1196139233","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196139233?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:32","pubTimestamp":1782268373,"startTime":"0","endTime":"0","summary":"Giant Biogene (02367) saw its shares rise more than 4% during the trading session. At the time of writing, the stock was up 2.4% to HK$25.56, with a turnover of HK$46.32 million.The movement follows...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","02367","159883","BK1574","BK1583","BK1100","09996","SG9999004311.SGD","VXUS","BK1207","BK4585","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190679722","title":"CICC Maintains \"Outperform Industry\" Rating on Giant Biogene, Adjusts Target Price to HK$40","url":"https://stock-news.laohu8.com/highlight/detail?id=1190679722","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190679722?lang=en_us&edition=fundamental","pubTime":"2026-06-22 11:13","pubTimestamp":1782097999,"startTime":"0","endTime":"0","summary":"CICC has released a research report reiterating its \"Outperform Industry\" rating for Giant Biogene (02367). The firm has revised the target price downward by 18% to HK$40, citing pressure on the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","SG9999004311.SGD","BK1207","LU2488822045.USD","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136961794","title":"Hong Kong Market Announcement Highlights: Three IPOs Launch Including Optical Module Supplier, Lenovo Plans $2 Billion Convertible Bond Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=1136961794","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136961794?lang=en_us&edition=fundamental","pubTime":"2026-06-18 09:00","pubTimestamp":1781744438,"startTime":"0","endTime":"0","summary":"Several companies have commenced their initial public offering processes in Hong Kong today.海光芯正 (01191), a supplier of optical modules, has begun its share offering. Several cornerstone investors,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0672654166.SGD","LU0128522157.USD","LU2488822045.USD","BK4585","BK1607","LU1366334651.USD","02672","BK1193","BK1515","SG9999004311.SGD","159938","LU0543330483.HKD","BK1161","LU0264606111.USD","LU1366334578.USD","LU0029875118.USD","LU2242644610.SGD","VXUS","BK1147","IE00B0JY6N72.USD","HK0000306685.HKD","IE0032431581.USD","BK1583","LNVGY","HK0000320223.HKD","LU0791590937.USD","01952","LU0572940350.SGD","00992","80992","LU0128525689.USD","BK1526","LU0320764755.SGD","LU0052756011.USD","BK1537","BK1207","02367","LU0791591158.USD","BK4588","01191","HK0000320264.USD","IPOS","09939","HK0000306701.USD","LU1235295612.USD","LU0310800965.SGD","LU1046422090.SGD","LU0049112450.USD","BNDW","LU0572939691.SGD","IE0034224299.USD","LU1267930227.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644710955","title":"Giant Biogene Unit Gets Registration Certificate for Neck Wrinkle Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2644710955","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644710955?lang=en_us&edition=fundamental","pubTime":"2026-06-17 18:23","pubTimestamp":1781691784,"startTime":"0","endTime":"0","summary":"Giant Biogene  unit Shaanxi Giant Biotechnology obtained a medical device registration certificate for its cross-linked recombinant collagen implant from China's National Medical Products Administration.The drug is intended for intradermal injection into the dermis layer of the neck to correct moderate to severe horizontal neck wrinkles, according to a Wednesday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2488822045.USD","SG9999004311.SGD","02367","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143675308","title":"Giant Biogene Secures NMPA Approval for World’s First Cross-linked Recombinant Type III Collagen Neck Filler","url":"https://stock-news.laohu8.com/highlight/detail?id=1143675308","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143675308?lang=en_us&edition=fundamental","pubTime":"2026-06-17 16:43","pubTimestamp":1781685800,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding Co., Ltd announced that its wholly owned subsidiary, Shaanxi Giant Biotechnology Co., Ltd, has obtained a Medical Device Registration Certificate (No. Guo Xie Zhu Zhun...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122050566","title":"Giant Biogene Secures Medical Device Registration for Its Cross-Linked Recombinant Collagen Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=1122050566","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122050566?lang=en_us&edition=fundamental","pubTime":"2026-06-17 16:38","pubTimestamp":1781685511,"startTime":"0","endTime":"0","summary":"In a significant development, Giant Biogene (02367) has announced that its wholly-owned subsidiary, Shaanxi Giant Biogene Technology Co., Ltd., has obtained a Medical Device Registration Certificate...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK1574","BK1207","02367","09996","BK1583","BK1100","LU2488822045.USD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644711945","title":"Giant Biogene Holding Co Ltd -  Certificate Issued by China National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2644711945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644711945?lang=en_us&edition=fundamental","pubTime":"2026-06-17 16:32","pubTimestamp":1781685159,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42O0LJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02367","BK1207","LU2488822045.USD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644119437","title":"Giant Biogene Holding Co - Receives China Medical Device Registration for Cross-Linked Recombinant Collagen Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2644119437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644119437?lang=en_us&edition=fundamental","pubTime":"2026-06-17 16:32","pubTimestamp":1781685159,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nFWN42O0LJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02367","LU2488822045.USD","BK1207","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644711995","title":"Giant Biogene wins China NMPA approval for neck-wrinkle recombinant collagen filler","url":"https://stock-news.laohu8.com/highlight/detail?id=2644711995","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644711995?lang=en_us&edition=fundamental","pubTime":"2026-06-17 16:32","pubTimestamp":1781685129,"startTime":"0","endTime":"0","summary":"Giant Biogene won China NMPA registration for its cross-linked recombinant type III collagen implant injection for intradermal neck wrinkle filling.The product entered NMPA priority review in December 2024.Giant Biogene called it the first cross-linked recombinant type III collagen filler globally for neck lines.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Giant Biogene Holding Co Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL7Vw2K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","LU2488822045.USD","02367","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642467850","title":"Assessing Giant Biogene Holding (SEHK:2367) Valuation After Approving Final And Special Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467850","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467850?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:14","pubTimestamp":1780996461,"startTime":"0","endTime":"0","summary":"Giant Biogene Holding (SEHK:2367) has put shareholder returns in focus after its AGM on 28 May 2026, approving both a final dividend and a separate special dividend for the 2025 financial year.\nSee our latest analysis for Giant Biogene Holding.\nThe dividend approvals come after a tough period for investors, with the stock posting a 1-year total shareholder return decline of 51.31% and a year to date share price return of 18.82% lower. However, the latest 1 day share price return of 1.46%...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/assessing-giant-biogene-holding-sehk2367-valuation-after-app","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/assessing-giant-biogene-holding-sehk2367-valuation-after-app","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","SG9999004311.SGD","LU2488822045.USD","BK1207","02367"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":0.0408},{"period":"1month","weight":0.1984},{"period":"3month","weight":-0.0338},{"period":"6month","weight":-0.0883},{"period":"1year","weight":-0.4896},{"period":"ytd","weight":-0.0675}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0473},{"period":"3month","weight":-0.0395},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0094},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.063748},{"month":2,"riseRate":0.75,"avgChangeRate":0.082293},{"month":3,"riseRate":0.75,"avgChangeRate":0.04973},{"month":4,"riseRate":0.75,"avgChangeRate":0.023756},{"month":5,"riseRate":0.25,"avgChangeRate":-0.038833},{"month":6,"riseRate":0.25,"avgChangeRate":-0.059254},{"month":7,"riseRate":0.5,"avgChangeRate":-0.005852},{"month":8,"riseRate":0.666667,"avgChangeRate":0.018735},{"month":9,"riseRate":0.666667,"avgChangeRate":0.061774},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.12614},{"month":11,"riseRate":0.333333,"avgChangeRate":0.019826},{"month":12,"riseRate":0.25,"avgChangeRate":0.047111}],"exchange":"SEHK","name":"GIANT BIOGENE","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GIANT BIOGENE(02367),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GIANT BIOGENE(02367) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GIANT BIOGENE,02367,GIANT BIOGENE股票,GIANT BIOGENE股票老虎,GIANT BIOGENE股票老虎国际,GIANT BIOGENE行情,GIANT BIOGENE股票行情,GIANT BIOGENE股价,GIANT BIOGENE股市,GIANT BIOGENE股票价格,GIANT BIOGENE股票交易,GIANT BIOGENE股票购买,GIANT BIOGENE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GIANT BIOGENE(02367),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GIANT BIOGENE(02367) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}